Back to Search
Start Over
P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 'MIDOTARG' PILOT TRIAL
- Source :
- HemaSphere, Vol 7, p e13145db (2023)
- Publication Year :
- 2023
- Publisher :
- Wiley, 2023.
- Subjects :
- Diseases of the blood and blood-forming organs
RC633-647.5
Subjects
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 7
- Database :
- Directory of Open Access Journals
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.77814a66397c4682a96aae9cc74087ce
- Document Type :
- article
- Full Text :
- https://doi.org/10.1097/01.HS9.0000968844.13145.db